✦ LIBER ✦

Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

✍ Scribed by Yukihiro Hasegawa; Shingo Takanashi; Yutaka Kanehira; Takao Tsushima; Tadashi Imai; Ken Okumura

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 204 KB
Volume: 91
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010301)91:5<964::aid-cncr1086>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma transforming growth factor-β1 lev

Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma

✍ Fengming Kong; Randy L. Jirtle; Dale H. Huang; Robert W. Clough; Mitchell S. Ans 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

## BACKGROUND. Plasma transforming growth factor-␤1 (TGF␤1) levels are increased in many malignancies at the time of diagnosis, including all forms of lung carcinoma. Therefore, the potential use of TGF␤1 as a plasma marker to predict the long term outcome of lung carcinoma patients treated with r

Transforming growth factor-β1 : A useful

Transforming growth factor-β1 : A useful tumor marker in patients with colorectal carcinoma?

✍ Alan D. Langerak; Harinder S. Garewal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

T he report by Shim et al. 1 in this issue of Cancer presents interesting data regarding the potential use of serum transforming growth factor (TGF)-␤1 levels as a tumor marker in patients with colorectal carcinoma. Their findings suggest that TGF-␤ may be helpful in predicting extent of disease and

Expression of tumor-associated antigen R

Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma

✍ Miiru Izumi; Yoichi Nakanishi; Ichiro Yoshino; Manabu Nakashima; Takeshi Watanab 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Expression of platelet-derived endotheli

Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma

✍ Shinsuke Saito; Nelson Tsuno; Hirokazu Nagawa; Eiji Sunami; Jin Zhengxi; Takuya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 1 views

## BACKGROUND. Platelet-derived endothelial cell growth factor (PD-ECGF) is an angiogenic factor that has potent chemotactic activity for endothelial cells. Although it is expressed in the majority of colorectal tumors, and some reports suggest that its high expression is related to poor prognosis,

Vascular endothelial growth factor expre

Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma : Association with angiogenesis and tumor progression

✍ Kimitoshi Inoue; Yuichi Ozeki; Toshiyuki Suganuma; Yoshiaki Sugiura; Susumu Tana 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the

Elevated serum levels of transforming gr

Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma : Its association with tumor progression and its significant decrease after curative surgical resection

✍ Kang Sup Shim; Kwang Ho Kim; Woon Sup Han; Eung Bum Park 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Background: Transforming growth factor-beta1 (tgf-beta1) acts as a potent inhibitor of cell growth and tumor progression but loss of this negative regulation can contribute to tumor development. some studies have reported an association between disease progression and tgf-beta1 expression in pat